Can-Fite Receives Eurasian Patent Allowance for Piclidenoson in Lowe Syndrome
The allowance supports development and commercialization of piclidenoson in Lowe syndrome.
Related stories
Goldman Sachs Adds Deutsche Bank Stock To Its European Conviction List
L impact | EQUITY | Nov 02, 2026, 03:52 PM UTC
Canada’s TSX Composite Rises 0.9% as Oil Prices Tumble
The S&P/TSX Composite Index was up 0.9% at 35,979.08 points as of 10:25 a.m. ET Monday, with lower oil prices lifting sentiment.
M impact | EQUITY | Nov 02, 2026, 03:50 PM UTC
Oracle Details $20 Billion Plan to Fund AI Buildout
Oracle disclosed details of its previously announced plan to raise $20 billion to fund AI infrastructure expansion. Its stock fell Monday.
M impact | EQUITY | Nov 02, 2026, 03:50 PM UTC
Engineers India Shares Jump 15% to Two-Week High After Q2 Results
Engineers India shares closed Monday up 15% at Rs.290, a two-week high, after upbeat September-quarter results. The stock has gained 44% in 2026.
M impact | EQUITY | Nov 02, 2026, 03:48 PM UTC
World Stocks Rebound as Oil Falls and Strong Data Is Published
Global equities rebounded as oil prices declined and strong economic data was published.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Carnelian, HDFC AMC and L&T Acquire 2.9% Stake in EAAA India Alternatives
The investors collectively acquired the stake through open-market transactions on EAAA India Alternatives’ first day of trading, November 2.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC